Clinical Trial Update: High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing high-dose dexamethasone plus thalidomide versus dexamethasone alone for newly diagnosed immune thrombocytopenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 2 | Status: WITHDRAWN